Lipid-lowering therapy and risk of coronary events

JAMA. 2003 Apr;289(16):2071; author reply 2071-2. doi: 10.1001/jama.289.16.2071-b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, HDL / blood
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / complications*
  • Hypercholesterolemia / drug therapy*
  • Hypertension / complications*
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Cholesterol, HDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors